PT - JOURNAL ARTICLE AU - Alexandra Kachaner AU - Cédric Lemogne AU - Julie Dave AU - Brigitte Ranque AU - Thomas de Broucker AU - Elodie Meppiel TI - <strong>Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19</strong>) AID - 10.1136/jnnp-2021-327899 DP - 2022 Nov 01 TA - Journal of Neurology, Neurosurgery &amp; Psychiatry PG - 1174--1180 VI - 93 IP - 11 4099 - http://jnnp.bmj.com/content/93/11/1174.short 4100 - http://jnnp.bmj.com/content/93/11/1174.full SO - J Neurol Neurosurg Psychiatry2022 Nov 01; 93 AB - Objectives To assess the diagnosis of somatic symptom disorder (SSD) in patients with unexplained neurological symptoms occurring after SARS-CoV-2 infection, also referred to as long COVID.Design Single-centre observational study.Participants Adult patients experiencing unexplained long-lasting neurological symptoms after mild COVID. Of the 58 consecutive patients referred in our centre, 50 were included.Intervention Patients were contacted for a standardised psychometric evaluation by phone, followed by a self-survey.Main outcome Positive diagnosis of SSD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5).Results Although the patients did not meet the DSM-5 criteria for a functional neurological symptom disorder specifically, SSD diagnosis based on DSM-5 criteria was positive in 32 (64%) patients. In the remaining 18 patients, SSD was considered possible given the high score on diagnostic scales. Physical examination were normal for all. Brain MRI showed unspecific minor white matter hyperintensities in 8/46 patients. Neuropsychological assessment showed exclusively mild impairment of attention in 14 out of 15 tested patients, in discrepancy with their major subjective complaint. Forty-five (90%) patients met criteria for Chronic Fatigue Syndrome. Seventeen (32%) patients were screened positive for mood-anxiety disorders, 19 (38%) had a history of prior SSD and 27 (54%) reported past trauma. Additional self-survey highlighted post-traumatic stress disorder in 12/43 (28%), high levels of alexithymia traits and perfectionism. Long-lasting symptoms had a major impact with a high rate of insomnia (29/43, 67%), psychiatric follow-up (28/50, 56%) and work or pay loss (25/50, 50%).Conclusion A majority of patients with unexplained long-lasting neurological symptoms after mild COVID met diagnostic criteria for SSD and may require specific management.Trial registration number NCT04889313.Data are available on reasonable request.